Plain-English translation of NCT07152002 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial testing a new medication called to see how safe it is and how your body handles it. Researchers will give some participants the medication (either as an injection under the skin or through an IV) and others a placebo (a dummy treatment with no active drug) to compare results. Blood tests will help researchers understand how the medication works in your body and what side effects might occur.
Researchers are in the very early stages of studying this medication to understand whether it could eventually help people manage weight-related conditions. Right now, they simply need to make sure the treatment is safe and well-tolerated before any larger studies can happen.
You would receive either the new medication or a placebo, given either as an injection under your skin or through an IV infusion into your arm. The study has multiple groups (called cohorts) that test different doses, starting with the lowest dose and gradually increasing to higher doses as safety is confirmed. Throughout the trial, you'll have blood tests to help researchers understand how your body processes the medication and monitor for any side effects.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Singapore